Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 29.36
-0.24 (-0.81%)
At close: Jan 21, 2026
SHA:688443 Revenue
Chongqing Genrix Biopharmaceutical had revenue of 162.16M CNY in the quarter ending September 30, 2025, with 1,199.88% growth. This brings the company's revenue in the last twelve months to 225.16M, up 1,560.46% year-over-year. In the year 2024, Chongqing Genrix Biopharmaceutical had annual revenue of 30.09M with 2,384.11% growth.
Revenue (ttm)
225.16M
Revenue Growth
+1,560.46%
P/S Ratio
46.98
Revenue / Employee
303.04K
Employees
743
Market Cap
10.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.09M | 28.88M | 2,384.11% |
| Dec 31, 2023 | 1.21M | 736.26K | 154.92% |
| Dec 31, 2022 | 475.24K | -38.72M | -98.79% |
| Dec 31, 2021 | 39.19M | 38.10M | 3,502.99% |
| Dec 31, 2020 | 1.09M | 1.06M | 3,393.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition